CRISPR Therapeutics AG logo

CRISPR Therapeutics AG

NEW
FRA:1CG (Switzerland)   Ordinary Shares
€ 50.45 -2.05 (-3.9%) Aug 28
At Loss
P/B:
3.19
Market Cap:
€ 4.79B ($ 5.55B)
Enterprise V:
€ 3.43B ($ 3.98B)
Volume:
250.00
Avg Vol (2M):
239.00
Trade In:

CRISPR Therapeutics AG Operating Data

CRISPR Therapeutics AG Competitors' Latest Operating Data

Operating data not available.

CRISPR Therapeutics AG (FRA:1CG) Operating Data Charts